keyword
https://read.qxmd.com/read/38164744/24-hour-urine-metanephrine-excretion-in-patients-diagnosed-with-adrenal-incidentaloma-impact-of-commonly-used-drugs-on-a-clinical-decision
#21
JOURNAL ARTICLE
Joanna Kokoszka, Marta Opalinska, Katarzyna Sitarz, Magdalena Kolasa, Monika Szewczyk, Jolanta Bugajska, Joanna Berska, Krystyna Sztefko, Alicja Hubalewska-Dydejczyk
INTRODUCTION: Incidentaloma is an adrenal tumor detected during diagnostic imaging performed for extra‑adrenal causes. Evaluation of metanephrine concentrations in a 24‑hour urine collection can be a significant challenge in patients with multiple medications and comorbidities. OBJECTIVES: The aim of this study was to evaluate the effect of commonly used groups of drugs on metanephrine levels in the 24‑hour urine collection. PATIENTS AND METHODS: A total of 1051 patients with adrenal mass below 10 Hounsfield units on unenhanced computed tomography were included in the study...
March 27, 2024: Polish Archives of Internal Medicine
https://read.qxmd.com/read/38152526/subthalamic-deep-brain-stimulation-in-parkinson-s-disease-a-boon-or-bane-a-single-centre-retrospective-observational-study-from-india
#22
JOURNAL ARTICLE
Darpanarayan Hazra, Gina Maryann Chandy, Amit Ghosh
Background  Subthalamic deep brain stimulation (STN-DBS) for refractory Parkinson's disease (PD) is more of a modality of treatment that is empirical, for which a physiological explanation is being sought. This study was done to determine the outcome and complications of patients undergoing STN-DBS for PD. Methods  This retrospective observational cohort study was conducted in an advanced neuromedicine facility in eastern India for 9 years (August 2013-August 2022), which included all patients undergoing STN-DBS...
September 2023: Asian Journal of Neurosurgery
https://read.qxmd.com/read/38151160/examining-the-features-of-neuroleptic-malignant-syndrome-in-anti-nmda-receptor-encephalitis-a-case-control-study
#23
JOURNAL ARTICLE
Jesus Ramirez-Bermudez, Miguel Restrepo-Martinez, Mariana Espinola-Nadurille, Victoria Martinez-Angeles, Juan Carlos Lopez-Hernandez, Laura E Hernandez-Vanegas, Francisco Martinez-Carrillo, Ramiro Ruiz-Garcia, Veronica Rivas-Alonso, Jose Flores-Rivera, Thomas A Pollak
BACKGROUND: Anti-N-methyl-D-aspartate receptor encephalitis (ANMDARE) is a neuroimmunological disorder that frequently improves with immunotherapy. Symptomatic treatment with antipsychotics is common in the early stages when psychiatric symptoms predominate, and their use has been associated with serious side effects including neuroleptic malignant syndrome (NMS). The observation of an adverse response to antipsychotics, raising the suspicion of NMS, has been included as a criterion for possible autoimmune psychosis...
December 25, 2023: Journal of the Academy of Consultation—Liaison Psychiatry
https://read.qxmd.com/read/38130041/concurrent-administration-of-serotonergic-antidepressants-and-ozanimod-in-participants-with-relapsing-multiple-sclerosis-from-the-open-label-extension-daybreak-trial
#24
JOURNAL ARTICLE
Robert T Naismith, Jeffrey A Cohen, Amit Bar-Or, Giancarlo Comi, Krzysztof W Selmaj, Hans-Peter Hartung, James K Sheffield, Anthony Krakovich, Daniel Tatosian, Chun-Yen Cheng, Jennifer Reardon, Vadim Khaychuk, Jon V Riolo, Diego Silva, Bruce Ac Cree
BACKGROUND: Monoamine oxidase (MAO) inhibitors can interact with selective serotonin reuptake inhibitors (SSRIs)/serotonin-norepinephrine reuptake inhibitors (SNRIs). There is clinical interest surrounding use of ozanimod with SSRIs/SNRIs because the major metabolites of ozanimod are weak inhibitors of MAO-B in vitro. OBJECTIVE: To evaluate the incidence of treatment-emergent adverse events (TEAEs) potentially related to serotonin accumulation (SA) during concomitant ozanimod and SSRI/SNRI use by performing analyses of data from an open-label, oral ozanimod 0...
December 21, 2023: Multiple Sclerosis: Clinical and Laboratory Research
https://read.qxmd.com/read/38055420/when-the-fever-will-not-stop-stop-the-pills-a-case-report
#25
César Ricardo Coimbra de Matos, Eduarda Maria da Conceição Sério Pereira Beirão, Rafael Simões Neves, António José Assunção, Rui Moreira Marques
BACKGROUND: Neuroleptic malignant syndrome (NMS) is a neurologic emergency potentially fatal. This rare side effect is most commonly associated with first-generation antipsychotics and less frequently with atypical or second-generation antipsychotics. The diagnosis relies on both clinical and laboratory criteria, with other organic and psychiatric conditions being ruled out. CASE REPORT: A 39-year-old female patient, who is institutionalized and completely dependent, has a medical history of recurrent urinary infections and colonization by carbapenem-resistant Klebsiella pneumoniae...
2023: São Paulo Medical Journal
https://read.qxmd.com/read/38034668/evaluation-of-neuroleptic-malignant-syndrome-induced-by-antipsychotic-drugs-using-spontaneous-reporting-system
#26
JOURNAL ARTICLE
Sakiko Hirofuji, Koumi Miyasaka, Mika Maezawa, Wataru Wakabayashi, Keita Oura, Satoshi Nakao, Nanaka Ichihara, Yuka Nokura, Moe Yamashita, Kensuke Matsui, Hideyuki Tanaka, Mayuko Masuta, Ichiro Ieiri, Kazuhiro Iguchi, Mitsuhiro Nakamura
Adverse events (AEs) of antipsychotic drugs include neuroleptic malignant syndrome (NMS), which presents complex clinical symptoms, resulting in a fatal outcome. In this study, the association between antipsychotic drugs and NMS was comprehensively evaluated by cluster and association analyses using the Japanese Adverse Drug Event Report (JADER) database. The analyses were performed using 20 typical antipsychotics (TAPs) alongside 9 atypical antipsychotics (AAPs). The Standardised MedDRA Queries (SMQ) database was used to analyze NMS (SMQ code: 20000044)...
November 2023: Heliyon
https://read.qxmd.com/read/38022067/severe-recurrence-of-neuroleptic-malignant-syndrome-usefulness-of-dexmedetomidine-for-antipsychotic-withdrawal
#27
Keisuke Maeda, Toshihisa Ichiba, Kenichiro Kashiwa, Yuji Okazaki
Neuroleptic malignant syndrome (NMS) is a potentially fatal side effect that occurs in patients taking antipsychotics. Patients with NMS are often forced to rechallenge antipsychotic medications to control the underlying psychiatric symptoms. We present a case of severe recurrence of NMS in a patient in whom the administration of antipsychotics was restarted two days after NMS resolution. A 19-year-old man with somatic symptom disorder had been transported for fever, tachycardia, rigidity, and disturbance of consciousness...
October 2023: Curēus
https://read.qxmd.com/read/38021641/challenges-in-the-clinical-diagnosis-of-lithium-toxicity-a-case-report
#28
Ahmad H Almadani, Fay H AlBuqami, Mohammed A Aljaffer
Lithium, a medication commonly used to treat bipolar disorders, has a narrow therapeutic index, putting patients at risk of lithium toxicity. Such toxicity could entail neurological-related complications and could be precipitated by several factors. In this paper, the authors discuss a case of a middle-aged woman taking lithium for bipolar disorder who presented to the emergency department with altered mental status, tremors, generalized weakness, and dysarthria. Multiple differential diagnoses were considered during her hospitalization, which included an admission to the intensive care unit...
October 2023: Curēus
https://read.qxmd.com/read/37992105/atypical-neuroleptic-malignant-syndrome-associated-with-mirtazapine-use
#29
Talha Ağaç, Hasan Gökçay, Mustafa Solmaz
No abstract text is available yet for this article.
2023: Psychiatria Danubina
https://read.qxmd.com/read/37962307/neuroleptic-malignant-syndrome-in-patients-with-dementia-experiences-of-a-single-memory-clinic
#30
JOURNAL ARTICLE
Ahmet Turan Isik, Derya Kaya, Mehmet Selman Ontan, Feyza Mutlay, Esra Ates Bulut, Fatma Sena Dost, Neziha Erken, Ali Ekrem Aydin
OBJECTIVES: Neuroleptic malignant syndrome (NMS) is a life-threatening condition that occurs as an adverse reaction to antipsychotic and antiemetic agents or sudden withdrawal of dopaminergic medications. Given the metabolic and functional reserves and the comorbidities in older adults, NMS may show an atypical course. METHODS: The medical records of patients with neurodegenerative diseases leading to dementia between 2013 and 2020 were reviewed for the diagnosis of NMS...
November 2023: Clinical Neuropharmacology
https://read.qxmd.com/read/37931952/neuroleptic-malignant-syndrome
#31
JOURNAL ARTICLE
Carolyn Michelle Tan, Alexander Kumachev
No abstract text is available yet for this article.
November 6, 2023: Canadian Medical Association Journal: CMAJ
https://read.qxmd.com/read/37930214/neuroleptic-malignant-syndrome-associated-with-lurasidone-a-case-report
#32
JOURNAL ARTICLE
Samuel Pàmpols-Pérez, Arnau Gisbert-Solà, Belen Resa-Pérez, Andrea Jiménez-Mayoral, Irene Forcada-Pach, Vicent Llorca-Bofi
No abstract text is available yet for this article.
November 2023: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/37892815/electrolyte-disturbances-related-to-sodium-and-potassium-and-electroconvulsive-therapy-a-systematic-review
#33
REVIEW
Adam Gędek, Michał Materna, Paweł Majewski, Anna Z Antosik, Monika Dominiak
INTRODUCTION: Electrolyte disturbances related to sodium and potassium affect patients with mental disorders undergoing electroconvulsive therapy (ECT). The objective of this study was to systematically summarize the data regarding ECT and electrolyte disturbances related to sodium and potassium. MATERIALS AND METHODS: A systematic literature review in accordance with PRISMA guidelines was conducted. Clinical studies of patients receiving ECT with electrolyte disturbances reported before or after treatment were included...
October 22, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/37891209/the-role-of-antipsychotics-and-other-drugs-on-the-development-and-progression-of-neuroleptic-malignant-syndrome
#34
JOURNAL ARTICLE
Yoji Kyotani, Jing Zhao, Kiichi Nakahira, Masanori Yoshizumi
Neuroleptic malignant syndrome (NMS) is a rare but serious and sometimes fatal complication in patients taking antipsychotic drugs, and its underlying mechanism still remains unclear. The pharmacotherapy for psychotic disorders is complicated and often involves a combination of two or more drugs, including drugs other than antipsychotics. In the present study, we used the Japanese Adverse Drug Event Report (JADER) database to broadly investigate the drugs associated with NMS, following their related pathways, as well as the drug-drug interactions (DDIs) in NMS...
October 27, 2023: Scientific Reports
https://read.qxmd.com/read/37886119/serotonin-syndrome-caused-by-a-cyp2c19-mediated-interaction-between-low-dose-escitalopram-and-clopidogrel-a-case-report
#35
Jianhong Wu, Jiao Yu, Kankan Qu, Jiajun Yin, Chunming Zhu, Xiaowei Liu
BACKGROUND: Serotonin syndrome has been recognized as a serious adverse reaction to antidepressants and is characterized by sudden or severe autonomic nerve dysfunction and neuromuscular symptoms. Without an accurate diagnosis and prompt treatment, serotonin syndrome progresses rapidly and can be life-threatening. It is usually related to the dose of 5-hydroxytryptamine drugs, and the dose is the basis for diagnosis. Therefore, serotonin syndrome induced by low-dose antidepressants rarely occurs, and clinicians are more likely to misdiagnose patients who take low-dose antidepressants with similar symptoms...
2023: Frontiers in Psychiatry
https://read.qxmd.com/read/37874611/a-case-of-neuroleptic-malignant-syndrome-in-the-context-of-lithium-toxicity-and-aripiprazole-use
#36
JOURNAL ARTICLE
Autumn R Schultz, Sarina Singh, Carolyn E Linek-Rajapaksha, Heather R Goode, Adam J Fusick
OBJECTIVE: Neuroleptic malignant syndrome (NMS) is a rare life-threatening condition that providers should be cognizant of when prescribing dopamine-receptor antagonists. Atypical antipsychotic agents were initially considered to have a lower risk of inducing the development of NMS compared with conventional antipsychotic. Considerable evidence, however, has suggested that atypical antipsychotics are associated with NMS, including the partial dopamine agonist, aripiprazole. There is growing evidence that other psychotropics, including lithium, cause this condition...
October 20, 2023: Clinical Neuropharmacology
https://read.qxmd.com/read/37871241/neuroleptic-malignant-syndrome-associated-with-lurasidone-a-case-report
#37
JOURNAL ARTICLE
Samuel Pàmpols-Pérez, Arnau Gisbert-Solà, Belen Resa-Pérez, Andrea Jiménez-Mayoral, Irene Forcada-Pach, Vicent Llorca-Bofi
No abstract text is available yet for this article.
October 24, 2023: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/37800266/neuroleptic-malignant-syndrome-with-underlying-catatonia-a-case-report
#38
JOURNAL ARTICLE
Chloé Gilson, Denis Jacques, Thomas Dubois
No abstract text is available yet for this article.
October 2023: Psychiatria Danubina
https://read.qxmd.com/read/37791204/malignant-tourette-s-syndrome-in-an-adult-on-deep-brain-stimulation-presenting-with-rhabdomyolysis
#39
Varun Monga, Rohit Madan, Niraj Arora
Tourette's syndrome (TS) patients experiencing severe tics and behavioral disturbances can have a rare complication called rhabdomyolysis (RML), which is characterized by the breakdown of muscle tissue. The occurrence of RML poses a significant physical and emotional risk to patients with TS by impacting the quality of life and in some cases causing severe damage. In this case report, we present the first documented case of RML resulting from severe tics in an adult with a diagnosis of TS. The patient exhibited severe tics and self-injurious behaviors that led to elevated creatine kinase and a subsequent diagnosis of RML requiring hospitalization with a complex hospital course...
August 2023: Curēus
https://read.qxmd.com/read/37748136/elevated-creatine-phosphokinase-in-a-patient-on-a-long-acting-antipsychotic-a-challenging-presentation-similar-to-neuroleptic-malignant-syndrome
#40
JOURNAL ARTICLE
Sahar Ashraf, Hansini Kochhar, Charles Jenson, Brittany Griffin, Kaushal Shah, Zeeshan Mansuri, Anil Bachu
No abstract text is available yet for this article.
September 21, 2023: Primary Care Companion to CNS Disorders
keyword
keyword
22949
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.